Longeveron Inc.
LGVN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001721484
No open-market purchases or sales by Longeveron Inc. insiders were filed in the last 90 days; 39 institutions reported holding it in 13F filings for Q2 2026, worth $3.35M in total; no superinvestor holds it.
Q3 2022 vs. Q2 2022
How the institutions holding Longeveron Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 14 | 18 | +4 |
| Shares | 378.2K | 444.0K | +65.8K (+17.4%) |
| Value | $2.24M | $1.64M | −$600.4K (−26.8%) |
New holders (6)
Institutions that held Longeveron Inc. at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Susquehanna Fundamental Investments, LLC | 27,347 | $101.0K | 0.00% |
| XTX Topco Ltd | 10,683 | $40.0K | 0.01% |
| Squarepoint Ops LLC | 10,356 | $38.0K | 0.00% |
| BNP Paribas Arbitrage, SA | 700 | $2.59K | 0.00% |
| FMR LLC | 10 | $0 | 0.00% |
| Royal Bank of Canada | 54 | $0 | 0.00% |
Sold out (2)
Institutions that held Longeveron Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| UBS Group AG | 510 | $3.00K |
| Credit Suisse AG | 105 | $1.00K |